Jennifer Doudna

Jennifer Doudna has joined Synthego's advisory board. Doudna will advise Synthego on a variety of product, partnership, and business strategy initiatives in order to help direct the company's plans in the genome engineering space. Doudna joins former GlaxoSmithKline CEO and UnitedHealth Group Director Andrew Witty Director on the firm's advisory board.